Related Experiment Video
Updated: Jun 16, 2026
03:40
Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
Published on: December 20, 2024
Speaking the same language: The World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading
Linda Cox1, Desiree Larenas-Linnemann, Richard F Lockey
1Nova Southeastern University School of Osteopathic Medicine, Davie, Fla, USA. Lindaswolfcox@msn.com
The Journal of Allergy and Clinical Immunology
|February 11, 2010
Summary
Subcutaneous allergen immunotherapy (SCIT) can cause severe reactions. A proposed grading system aims to standardize the assessment of SCIT systemic reactions, guiding timely epinephrine administration for patient safety.
Area of Science:
- Allergy and Immunology
- Clinical Medicine
Background:
- Subcutaneous allergen immunotherapy (SCIT) effectively treats allergic conditions but carries a risk of life-threatening anaphylaxis.
- Adverse reactions to SCIT include local and systemic reactions (SRs), ranging from mild to fatal.
Purpose of the Study:
- To discuss a proposed grading system for SCIT systemic reactions.
- To aid in determining the appropriate timing for epinephrine administration during SCIT-induced SRs.
Main Methods:
- Review and discussion of a proposed classification system for SCIT SRs.
- Analysis of the severity spectrum of SCIT SRs.
Main Results:
- SCIT SRs require careful management, with epinephrine as the primary treatment.
- A standardized grading system is needed to guide clinical decisions on epinephrine use.
Conclusions:
- A uniform grading system for SCIT SRs is crucial for accurate assessment and timely intervention.
- Implementing a grading system can improve patient safety by standardizing epinephrine administration protocols.
Related Concept Videos
01:30Allergic Reactions: Anaphylaxis
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
01:27Allergic Drug Reactions
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
02:06Allergic Reactions
Overview
00:42Cross-reactivity
Overview
01:30Drug Toxicity: Allergic Reactions
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
01:19Hypersensitivity Reactions: Immune-Complex Reactions
Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...